Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study.

Objective: To compare the efficacy of different therapies in the treatment of macular edema associated with retinal vein occlusion (RVO).

Design: This is a nonrandomized, multicenter collaborative study.

Participants: 86 retina specialists from 29 countries provided clinical information, including choice of treatment and outcome, on 2,603 patients with macular edema including 738 cases of RVO.

The Characteristics and the Pharmacological Management of Cancer Pain and Its Effect on the Patients' Daily Activities and their Quality of Life: A Cross - Sectional study from Malaysia.

Context: Pain is a major health care problem for the patients with cancer and one of the most frequent and disturbing cancer related symptoms.

Aim: To study the characteristics of pain in cancer patients and its pharmacological management by using a subjective self-assessment questionnaire and the World Health Organization (WHO)analgesic ladder for pain management.

Settings And Designs: This study was conducted in the Oncology Wards of Penang Hospital, Penang, Malaysia.

Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.

Introduction: Hypercalcemia is mainly caused by bone resorption due to either secretion of cytokines including parathyroid hormone-related protein (PTHrP) or bone metastases. However, hypercalcemia may occur in patients with or without bone metastases. The present study aimed to describe the effect of chemotherapy treatment, regimens and doses on calcium levels among breast and lung cancer patients with hypercalcemia.

Association and correlation of different chemotherapeutic regimens and doses with onset and severity of anemia among solid cancer patients.

Introduction: Anemia is considered as one of the most frequent hematological demonstration of malignant diseases, which lead to momentous impairment in every tissues and organs of cancer patients and put them under serious stress. This major problem may arise because of the underlining diseases (i.e.

Fever/clinical signs and association with neutropenia in solid cancer patients--bacterial infection as the main cause.

Introduction: Neutropenia remains one of the serious side effects of chemotherapeutics drugs making cancer patients face serious risk of infections. Fever and clinical signs are considered as important indicators. The objectives of this study were to assess fever and clinical signs with neutropenia onset and/ or severity in solid cancer cases, using culture tests to determine the type of bacteria predominating, whether gram positive or gram negative.

Filgrastim and antibiotics treatment reduces neutropenia severity in solid cancer patients.

Introduction: Neutropenia has a detrimental effect on cancer patients' quality of life, also possibly resulting in a reduction in the chemotherapy dose which could lead to an increment in the size of a cancer. The main danger associated with neutropenia is the risk of bacterial, fungal or viral infection, which may lead to patient death. Treatment including granulocyte-colony stimulating factors (G-CSF, filgrastim) so as to increase the body immunity is given to neutropenic patients with no infection i.